The FDA has on 18 January 2013, approved octaplas,from Octapharma, a pooled plasma (human) blood product for the replacement of...
Fibrinogen replacement is critical in major obstetric haemorrhage (MOH). Purified, pasteurised fibrinogen concentrate appears to have benefit over cryoprecipitate in ease of administration and safety but is unlicensed...